Aileron Therapeutics, Inc. (ALRN)

NASDAQ: ALRN · IEX Real-Time Price · USD

5.00

+0.75 (17.65%)

At close: Apr 18, 2024, 4:00 PM

5.11

+0.11 (2.20%)

After-hours: Apr 18, 2024, 7:57 PM EDT

Aileron Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015
Net Income	-15.73	-27.33	-26.16	-21.16	-29.37	-31.55	-22.65	-18.2	-12.95
Depreciation & Amortization	0.12	0.17	0.12	0.16	0.16	0.22	0.13	0.23	0.33
Share-Based Compensation	1.19	2.08	2.26	1.89	2.12	3.28	1.75	0.69	0.63
Other Operating Activities	-5.39	0.21	0.03	-1.38	0.62	0.12	0.2	2.19	0.22
Operating Cash Flow	-19.81	-24.87	-23.75	-20.48	-26.47	-27.93	-20.53	-15.01	-11.71
Capital Expenditures	0.04	0	-0.09	0.2	-0.15	-4.42	-0.14	0	-0.09
Acquisitions	-0.1	0	0	0	0	0	0	0	0
Change in Investments	16.25	26.46	-35.83	6.21	-2.66	29.11	-38.77	0	10.01
Other Investing Activities	-	-	-	-	-	-	-	-0.03	0.71
Investing Cash Flow	16.2	26.46	-35.92	6.41	-2.81	24.69	-38.91	-0.03	10.63
Share Issuance / Repurchase	0	0	55.66	15.41	23.96	0.04	50.12	-0.16	-1.27
Debt Issued / Paid	15.79	0	0	0.39	0	2.47	0	0	0
Other Financing Activities	-	-	-	-	-	-	0.47	32.14	-0.09
Financing Cash Flow	15.79	0	55.66	15.8	23.96	2.52	50.59	31.99	-1.36
Exchange Rate Effect	-0.06	0	0	0	0	0	0	0	0
Net Cash Flow	12.12	1.59	-4.01	1.74	-5.32	-0.72	-8.85	16.95	-2.44
Free Cash Flow	-19.77	-24.87	-23.85	-20.27	-26.63	-32.35	-20.67	-15.01	-11.8
Free Cash Flow Per Share	-4.30	-5.48	-5.37	-11.63	-21.70	-43.90	-55.55	-698.84	-589.15

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).